v1
High CD33-antigen loads in peripheral blood limit the efficacy of gemtuzumab ozogamicin (Mylotarg) treatment in acute myeloid leukemia patients.
Identifier:nobleid.org/w1/20260515/DF7C11AC
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/DF7C11AC)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims